Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mepivacaine hydrochloride 3% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
|
Mepivacaine hydrochloride 3% cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
|
Mepivacaine hydrochloride 3% cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
|
Mepivacaine hydrochloride 3%/levonordefrin 1:20,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
|
Mepivacaine hydrochloride 30mg/sodium chloride 3mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
|
Levonordefrin 50mcg/mepivacaine hydrochloride 20mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
|
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
2 |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
2 |
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
2 |
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mepivacaine hydrochloride |
Inferred relationship |
Some |
2 |